Balanced news tone
News Sentiment
2228 sentiment intelligence
XtalPi Holdings Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
73/100 classification confidence.
directly relevant articles
high-authority source matches
+0.3% over one week, +12.5% over four weeks, trend inactive, and near fair-value range.
XtalPi Biopharma GPCR Pact Tests AI Drug Discovery And Revenue Potential
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
XtalPi Biopharma GPCR Pact Tests AI Drug Discovery And Revenue Potential
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jun 2026 07:00
- Source
- simplywall.st
XtalPi Holdings (SEHK:2228) Stock Valuation Check After Recent Weak Momentum
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 14 Jun 2026 07:00
- Source
- Market source
Chinese AI drug researcher XtalPi expects to turn first annual profit
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 03 Mar 2026 08:00
- Source
- South China Morning Post
XtalPi’s 615% jump in drug revenue highlights China’s biotech boom
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 Aug 2025 07:00
- Source
- South China Morning Post
Xtalpi finalizes $6B AI drug discovery deal with Dovetree
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 12 Aug 2025 07:00
- Source
- BioWorld News
Tencent-Backed AI Drug Researcher Xtalpi’s Shares Double On Revenue Rise
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 Sep 2024 07:00
- Source
- Forbes
Tencent-Backed AI Drug Discovery Startup Xtalpi Rises In Hong Kong Debut
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jun 2024 07:00
- Source
- Forbes
AI drug researcher XtalPi lists in Hong Kong amid U.S.-China rivalry
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jun 2024 07:00
- Source
- Nikkei Asia
Tencent-Backed AI Drug Discovery Startup Xtalpi Files For Hong Kong IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Dec 2023 08:00
- Source
- Forbes